Publicacións (22) Publicacións de Maria Dolores Castro Vilanova

2023

  1. Cenobamate in real-life setting: final outcomes of an expanded access program

    35th International Epilepsy Congress, Dublin, IRELAND

  2. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

2021

  1. Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente

    Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268

  2. Lymphocytic meningitis due to mediterranean botanical fever. About a case

    Neurologia Argentina, Vol. 13, Núm. 3, pp. 188-191

  3. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study

    Epilepsy Research, Vol. 172

  4. Quality of life in adult patients with idiopathic generalised epilepsy. The EPILAK study

    Revista de Neurologia, Vol. 72, Núm. 6, pp. 195-202

  5. Relationship between sleep quality and cognitive performance in patients with epilepsy

    Epilepsy and Behavior, Vol. 122

2020

  1. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119

  2. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Levels of anger in epilepsy patients treated with eslicarbazepine acetate

    Acta Neurologica Scandinavica, Vol. 140, Núm. 1, pp. 48-55

  3. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

2018

  1. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

    The Lancet Neurology, Vol. 17, Núm. 6, pp. 530-538

  2. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting

    Epilepsy Research, Vol. 145, pp. 51-54

2015

  1. Experiencia clínica con lacosamida en Galicia: Estudio GALACO

    Revista de Neurologia, Vol. 61, Núm. 12, pp. 536-542

2009

  1. Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: Results at 6 years

    Neurologia, Vol. 24, Núm. 6, pp. 360-365

2002

  1. Hallazgos mediante resonancia magnética en un paciente con anosmia no postraumática

    Revista de Neurologia, Vol. 34, Núm. 12, pp. 1135-1137

2000

  1. Intracranial tuberculomas in an immunocompetent patient

    Revista de neurologia, Vol. 31, Núm. 1, pp. 96

1999

  1. Spinal cord infarction-ischemia

    Revista de Neurologia, Vol. 29, Núm. 10, pp. 977-980

1998

  1. Paciente alcohólico con alteraciones neuropsiquiátricas y de la marcha

    Revista Clinica Espanola, Vol. 198, Núm. 4, pp. 247-248